Moberg Pharma announces the appointment of Cindy Wong as Chief Medical Officer.
Wong will during the fall be joining the management team at Moberg Pharma coming from a previous position as Vice President and Head of Global Clinical Development at Metz Pharmaceuticals GmbH.
International experience in clinical development and registration of new products
Wong brings international experience in clinical development and registration of new products in a number of treatment areas including Dermatology, states Moberg Pharma. She has held positions as Vice President and Head of Global Clinical Development at Metz Pharmaceuticals GmbH and Chief Medical Officer at Q-Med/Galderma, as well as senior positions at regulatory authorities in both Sweden and Australia. Wong is board certified in internal medicine and clinical immunology. She is a medical graduate from the University of Adelaide and has completed postgraduate training in Internal Medicine, Clinical Immunology and Immunopathology.
“We look forward to welcoming Cindy to Moberg Pharma. She will be joining the company in a highly exciting stage as we recently completed phase 3-trials for MOB-015, where she will be adding valuable experience from the development, registration and commercialization of novel treatments,” says Anna Ljung, CEO Moberg Pharma.
Photo: Moberg Pharma
